The STAT3 inhibitor galiellalactone inhibits the generation of MDSC‐like monocytes by prostate cancer cells and decreases immunosuppressive and tumorigenic factors
Rebecka Hellsten(Lund University), Anders Bjartell(Malmö University)
Cited by 70
Related Papers
Galiellalactone Is a Direct Inhibitor of the Transcription Factor STAT3 in Prostate Cancer Cells
|Journal of Biological Chemistry|2014|91
Cystatin C Is Downregulated in Prostate Cancer and Modulates Invasion of Prostate Cancer Cells via MAPK/Erk and Androgen Receptor Pathways
|PLoS ONE|2009|65
Cystatin C Is Highly Expressed in the Human Male Reproductive System
|Journal of Andrology|2004|37
Inhibition of STAT3 augments antitumor efficacy of anti-CTLA-4 treatment against prostate cancer
|Cancer Immunology Immunotherapy|2021|33